Xilio Therapeutics Competitors and Similar CompaniesClear all
Xilio Therapeutics's competitors and similar companies include RAPT Therapeutics.
 Xilio Therapeutics Xilio Therapeutics (formerly Akrevia Therapeutics) is a biopharmaceutical company focused on developing targeted immuno-oncology therapeutics. |  RAPT Therapeutics RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents. | |
Founding Date | Founding Date 2015 | Founding Date 2015 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Waltham, US HQ | Locations South San Francisco, US HQ |
Employees | Employees 69 | Employees 64 |
Valuation ($) | Valuation ($) 43.5 m | Valuation ($) 69.8 m |
Financial | ||
Net income | Net income ($35m) (FY, 2025) | Net income ($129.9m) (FY, 2024) |
Funding | ||
Total funding raised | Total funding raised $ 233m | Total funding raised $ 176m |
For sources of this data, please see the company profile
View Company Profiles
RAPT Therapeutics
HQ
South San Francisco, US
Employees
64
RAPT Therapeutics (also known as FLX Bio) is a biopharmaceutical company that develops and commercializes immuno-oncology agents.
View company